How Long Should You Try Before Getting Fertility Testing?
The right time to seek fertility testing depends chiefly on age, how long you have been trying to conceive, and whether either partner has a health condition or history that could affect fertility. The American Society for Reproductive Medicine (ASRM) recommends evaluation after 12 months of regular, unprotected intercourse when the person trying to become pregnant is younger than 35, after six months at ages 35–40, and sooner than six months for people over 40. Testing should begin without waiting when there are known risk factors, such as irregular or absent periods, prior chemotherapy, or suspected male-factor infertility. These timelines are guides—not a reason to delay care when something seems wrong.
When to seek fertility testing by age and time trying
Fertility evaluation is a medical assessment of factors that may make conception difficult, including ovulation, the reproductive tract, and sperm production and function. ASRM defines infertility as a disease or condition characterized by the failure to achieve a successful pregnancy after 12 months or more of regular, unprotected sexual intercourse, while also recommending earlier evaluation based on age and medical history. The American College of Obstetricians and Gynecologists (ACOG) gives similar advice: start an evaluation after 12 months if younger than 35, after six months if 35 or older, and consider immediate evaluation over 40.
These timeframes reflect the effect of age on the chance of conception, especially as egg number and quality decline over time. They do not mean everyone will conceive within a set number of months, nor do they predict an individual’s outcome. In the United States, about one in five married women ages 15–49 with no prior births are unable to become pregnant after one year of trying, according to the Centers for Disease Control and Prevention (CDC). A clinical evaluation can identify treatable issues and help determine whether continued trying, treatment, or referral is appropriate.
Under age 35: after 12 months
For people younger than 35 with regular menstrual cycles and no known fertility risks, seek an evaluation after 12 months of regular, unprotected intercourse without pregnancy. “Regular” generally means sex every two to three days throughout the cycle, or sex timed around ovulation; there is no need to follow a rigid schedule if that creates stress. A clinician may start with a history and basic tests rather than immediately recommending treatment.
Ages 35–40: after six months
At ages 35–40, contact a healthcare professional after six months of trying. Because fertility can decline with age, waiting a full year may unnecessarily postpone diagnosis and care. The appropriate next step depends on the person’s history, test results, preferences, and access to treatment; six months is a prompt for assessment, not an automatic indication for assisted reproduction.
Over 40: seek advice promptly
People over 40 should consider an evaluation as soon as they begin trying to conceive, rather than waiting six or 12 months. This recommendation recognizes that time may be especially important at older reproductive ages. A clinician can discuss testing and options in the context of individual health, goals, and circumstances.
When fertility testing should happen sooner
The standard waiting periods apply mainly when there are no signs of a fertility problem. ASRM advises that evaluation should not be delayed when medical history or symptoms point to a possible cause. Testing may be useful for both partners at the same time, since fertility difficulties can involve one or both partners.
Irregular or absent menstrual cycles
Very irregular periods, cycles consistently shorter than about 21 days or longer than about 35 days, or absent periods can indicate that ovulation is infrequent or not occurring. Conditions such as polycystic ovary syndrome, thyroid disorders, and elevated prolactin can affect ovulation. A healthcare professional can assess the pattern and decide whether hormone testing or other evaluation is appropriate.
Known reproductive or medical risk factors
Seek advice sooner with a history of endometriosis, pelvic inflammatory disease, ectopic pregnancy, pelvic or reproductive surgery, or certain uterine or tubal conditions. Cancer treatment involving chemotherapy or radiation can also affect fertility. Chronic illnesses and some medications may matter as well, so discuss plans to conceive with a clinician rather than stopping prescribed treatment on your own.
Possible sperm-related concerns
A partner with a history of undescended testicles, testicular injury or surgery, chemotherapy, sexual or ejaculatory difficulties, or prior abnormal semen results should raise the issue early. A semen analysis is a common initial test of sperm concentration, movement, and shape. Since male factors contribute to many cases of infertility, ASRM recommends evaluating both partners rather than focusing only on the person who would carry a pregnancy.
Repeated pregnancy loss or other concerns
Repeated miscarriages are different from difficulty conceiving, but they also warrant medical discussion. People with concerns about sexual pain, possible sexually transmitted infections, or a family history of conditions that could affect fertility can ask for guidance before reaching the usual time threshold. A clinician can clarify which assessment fits the concern.
What a fertility evaluation usually includes
A fertility evaluation looks for likely explanations and guides next steps; it does not always produce a single definitive answer. ASRM recommends a systematic, cost-conscious approach based on medical history, age, duration of trying, and relevant risk factors. Testing is generally directed at both partners where applicable.
Medical history and ovulation assessment
The clinician may ask about menstrual cycles, prior pregnancies, health conditions, medications, surgeries, sexual timing, and how long the couple has been trying. Cycle history can help determine whether ovulation is likely; targeted blood tests or other assessments may be used when indicated. Not everyone needs every available hormone test.
Uterus and fallopian tubes
Depending on the history, evaluation may include pelvic imaging to examine the uterus and ovaries, and a test to see whether the fallopian tubes are open. A hysterosalpingogram is one common imaging procedure for assessing tubal patency and the uterine cavity. The clinician chooses tests based on the question being investigated, rather than ordering a fixed panel for everyone.
Semen analysis and partner evaluation
A semen analysis is often among the first tests when sperm may be involved. If the result is abnormal, a clinician may recommend repeating it or arranging further assessment, since semen measures can vary. Reviewing both partners’ histories early can prevent delays and unnecessary testing.
What to do while arranging an appointment
Record cycle dates, relevant symptoms, medications, prior diagnoses, and how often intercourse occurs. If desired, intercourse every one to two days during the fertile window can help maximize the chance of conception; ASRM notes that the fertile window spans the six days ending on ovulation. However, frequent intercourse throughout the cycle is also a reasonable approach, and ovulation-prediction tools are optional—not a substitute for evaluation when the recommended timeframe has passed.
Ask a primary-care clinician, obstetrician-gynecologist, or fertility specialist which tests are appropriate and whether both partners should attend. Before testing, check insurance coverage and costs, as benefits vary. Avoid starting supplements, hormone medicines, or fertility treatments without professional advice; some interventions are ineffective or can carry risks.
Conclusion: use the timeline, but do not ignore risk factors
For people without known fertility concerns, the usual guide is 12 months of trying if younger than 35, six months at ages 35–40, and prompt evaluation over 40. Irregular or absent periods, reproductive-health conditions, cancer treatment, or possible sperm-related issues are reasons to ask for help sooner. Fertility testing can assess ovulation, reproductive anatomy, and sperm, helping patients and clinicians make informed next-step decisions. If you have reached the relevant threshold—or have a risk factor—contact a healthcare professional and ask about an evaluation tailored to your situation.
Sources: American Society for Reproductive Medicine, “Fertility evaluation of infertile women: a committee opinion” (2021), https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2021/; American College of Obstetricians and Gynecologists, “Evaluating Infertility,” https://www.acog.org/womens-health/faqs/evaluating-infertility; Centers for Disease Control and Prevention, “Infertility FAQs,” https://www.cdc.gov/reproductive-health/infertility-faq/index.html; American Society for Reproductive Medicine, “Optimizing natural fertility: a committee opinion” (2022), https://www.asrm.org/practice-guidance/practice-committee-documents/optimizing-natural-fertility-a-committee-opinion-2022/.